Fertility Services & IVF Technology Market Size (2026-2030)

In 2025, the Global Fertility Services & IVF Technology Market was valued at approximately USD 53 Billion and is projected to reach around USD 82.30 Billion by 2030, expanding at a CAGR of about 9.2% during 2026–2030.

Fertility Services & IVF technologies help increasing the accuracy and efficiency of assisted reproductive techniques (ART) by optimizing embryo selection, improving treatment protocols, and personalizing fertility care services.

One important trend in the global fertility market is the growing integration of artificial intelligence (AI) and digital health solutions in many fertility treatments. For instance, AI-powered embryo grading systems help embryologists categorize the most viable embryos for implantation, augmenting the success rates of IVF procedures.

This trend is redefining the fertility landscape by improving treatment success rates, reducing costs, and increasing access to fertility care worldwide.

Key Market Insights

According to World Health Organization data released in April 2023, roughly 1 in 6 people worldwide face infertility at some stage in their lives. The condition affects populations quite evenly, with prevalence estimated at about 17.8% in high-income countries and 16.5% in low- and middle-income regions. These figures highlight a clear and growing need to make fertility care more accessible, affordable, and reliable.

Infertility is not limited to one gender; it impacts both men and women. For instance, around 10% of women aged 15 to 44 in the United States experience difficulties with fertility.

In March 2023, the Centers for Disease Control and Prevention highlighted a continuing rise in the age at which women in the U.S. have their first child, reflecting a broader shift toward delayed parenthood. Data shows that the average age of first-time mothers reached about 27.5 years in 2023, up from 26.6 years in 2016, indicating a steady upward trend. As a result of the rising infertility rates and the increasing awareness of fertility treatment options, there is a significant surge in demand for ART services worldwide.

In February 2024, a study published in the Journal of Assisted Reproduction and Genetics reported that AI-powered embryo assessment tools were able to identify viable embryos more accurately during IVF procedures. The technology helped improve pregnancy outcomes while also reducing the number of treatment cycles required for successful conception.

In September 2023, an article published by the National Institutes of Health highlighted the growing use of AI-based predictive models in fertility clinics. These systems analyze factors such as medical history, hormone levels, and genetic information to support more personalized fertility treatments and improve the overall effectiveness of assisted reproductive technologies.

In October 2024, an article published by the American Society for Reproductive Medicine noted that the cost of a single IVF cycle in the U.S. typically ranges from USD 12,000 to USD 25,000, not including medication costs. Limited insurance coverage for fertility treatments continues to be a major barrier, making assisted reproductive care financially challenging for many individuals and couples.

Research Methodology

1. Scope & definitions

• Operating revenue/value pool across fertility services and IVF technologies; excludes unrelated gynecology and general diagnostics
• Standardized definitions for treatment types, technologies, patient types, and end users per data dictionary
• Geography: global with regional splits; Timeframe: historical, base year, and forecast period
• MECE segmentation; strict rules to prevent overlap and double counting

2. Evidence collection (primary + secondary)

• Primary interviews across fertility clinics, hospitals, IVF labs, equipment suppliers, and distributors
• Expert validation from clinicians, embryologists, and lab managers across regions
• Secondary sources: company filings, audited financials, investor presentations, clinical registries, peer-reviewed journals
• Relevant regulators/standards bodies/industry associations specific to Fertility Services & IVF Technology Market (named in-report)
• All key claims supported with verifiable, source-linked evidence within the report

3. Triangulation & validation

• Bottom-up sizing from clinic volumes, treatment cycles, and pricing benchmarks
• Top-down sizing using healthcare expenditure and fertility service penetration rates
• Cross-verification with company revenues and disclosures where available
• Bias controls: conflicting-source reconciliation, outlier treatment, and interview cross-checks

4. Presentation & auditability

• Transparent assumptions, formulas, and segmentation mapping disclosed
• Traceable data lineage with source citations for each key datapoint
• Reproducible models with audit trails enabling independent verification
• Consistent units, definitions, and version-controlled updates across deliverables

Market Drivers

Rising infertility rates increasing the need for fertility treatments driving market growth.

The growing incidence of infertility, driven by factors such as changing lifestyles, delayed pregnancies, hormonal disorders, stress, and other health-related conditions, is fueling demand for fertility care worldwide. As reproductive challenges become more common among both men and women, more individuals and couples are turning to medical support to improve their chances of conception.

This rising demand is encouraging the adoption of assisted reproductive technologies (ART), including procedures such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), and fertility preservation methods like egg and embryo freezing. Growing awareness, improving success rates, and expanding access to fertility services are also supporting the wider acceptance of these treatments.

Lifestyle-related health issues contributing to declining fertility rates.

Modern lifestyle habits and environmental factors are increasingly being associated with reduced fertility among both men and women. High stress levels, obesity, smoking, poor dietary patterns, and exposure to environmental pollutants have all been identified as factors that can negatively affect reproductive health and fertility outcomes.

As fertility-related concerns continue to rise, there is growing demand for advanced reproductive treatments and supportive fertility solutions. This has encouraged greater adoption of assisted reproductive technologies, fertility monitoring tools, and personalized treatment approaches aimed at improving conception success rates.

Market Restraints

The rising cost of fertility treatments remains a major challenge for the growth of the fertility services market, particularly in developing countries where access to specialized healthcare is already limited. Advanced reproductive procedures such as In Vitro Fertilization (IVF) and egg freezing often require significant financial investment, with treatment expenses reaching thousands of dollars for a single cycle.

For many individuals and couples, these costs can become difficult to manage, especially since multiple treatment cycles are often needed to achieve a successful pregnancy. Limited insurance support and out-of-pocket expenses further add to the financial burden, discouraging some patients from pursuing or continuing fertility treatment. As a result, affordability concerns continue to restrict wider adoption of assisted reproductive technologies and may slow overall market growth.

Market Opportunities

The integration of artificial intelligence into fertility care is transforming assisted reproductive technologies (ART) by improving treatment accuracy and supporting better clinical outcomes. AI-based systems are increasingly being used to assist with embryo selection, treatment planning, and personalized fertility care, helping clinics improve the chances of successful pregnancies.

Advanced AI algorithms can monitor embryo development in real time and identify embryos with a higher likelihood of successful implantation. This not only helps improve IVF success rates but also reduces the risk of unsuccessful treatment cycles and repeated procedures for patients.

AI-powered tools are also being used for hormone tracking, genetic screening, and predictive analysis, enabling fertility specialists to make more informed and data-driven decisions. By tailoring treatment plans to an individual’s medical history and reproductive profile, these technologies are helping deliver more personalized and efficient fertility care.

How this market works end-to-end

The market operates as a tightly linked clinical and technological workflow:

1. Patient intake begins with diagnosis across female, male, or combined infertility cases.
2. Treatment selection follows, choosing between IUI, IVF, or advanced methods like ICSI.
3. Pre-treatment testing includes genetic screening and hormonal analysis.
4. Egg retrieval and sperm collection are performed using specialized clinical tools.
5. Fertilization occurs in controlled lab environments using IVF or ICSI methods.
6. Embryo monitoring uses imaging systems and time-lapse technology to assess viability.
7. Cryopreservation stores embryos or gametes for future use.
8. Embryo transfer completes the cycle, followed by monitoring and follow-up care.

Across this flow, clinics rely on imaging systems, lab equipment, and cryopreservation infrastructure. Fertility clinics dominate execution, while hospitals and surgical centers support complex cases. Cryobanks enable long-term storage and donor services.

What matters most when evaluating claims in this market

The decision lens

1. Define scope clearly
   Check if the report covers both services and technologies or only one layer.
2. Evaluate segmentation depth
   Ensure treatment types, patient types, and technologies are separated without overlap.
3. Check sizing approach
   Look for both bottom-up (cycle-based) and top-down (healthcare spend) methods.
4. Assess real-world validation
   Verify if insights are backed by clinic-level data and expert interviews.
5. Compare end-user insights
   Understand how clinics, hospitals, and cryobanks differ operationally.
6. Review assumptions
   Look for transparency in pricing, success rates, and adoption trends.

The contrarian view

This market is often oversimplified. Many reports treat IVF as a single category, ignoring differences between ICSI, genetic testing, and cryopreservation. This leads to misleading conclusions.

Another issue is double counting. Equipment sales and service revenues are sometimes combined without clear boundaries, inflating market size.

Success rates are also misused. Aggregated numbers hide key variables like patient age or condition, making comparisons unreliable.

Finally, many analyses assume uniform adoption of advanced technologies. In reality, access varies widely by geography and clinic type.

Practical implications by stakeholder

Fertility Clinics

• Must invest in advanced lab technologies to remain competitive
• Need to optimize patient segmentation for better outcomes

Hospitals

• Focus on complex and high-risk cases rather than routine cycles
• Integrate fertility services with broader reproductive care

Equipment Providers

• Demand is shifting toward integrated lab solutions, not standalone devices
• Must demonstrate clinical outcome improvements, not just features

Cryobanks

• Growth depends on long-term storage and donor service expansion
• Require strong compliance and tracking systems

Patients

• Choices increasingly depend on clinic technology and success transparency
• Cost considerations extend beyond single treatment cycles

FERTILITY SERVICES & IVF TECHNOLOGY MARKET REPORT COVERAGE:

Market Segmentation

Fertility Services & IVF Technology Market – By Treatment Type

• Introduction/Key Findings
• In Vitro Fertilization (IVF)
• Intracytoplasmic Sperm Injection (ICSI)
• Artificial Insemination (IUI)
• Egg & Embryo Freezing (Cryopreservation)
• Donor Services (Egg/Sperm/Embryo Donation)
• Genetic Testing (PGT)
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

In 2025, the In Vitro Fertilization (IVF) segment accounted for the largest share of the fertility services market, driven by rising infertility rates, growing reproductive tourism, and increasing adoption of AI-based technologies to improve treatment success rates and efficiency.

Meanwhile, the fertility preservation segment is expected to register the fastest growth during the forecast period. Increasing awareness about egg and embryo freezing, rising demand from cancer patients, and advancements in cryopreservation technologies are contributing to the rapid expansion of this segment. Growing acceptance of diverse family structures and higher demand for assisted reproductive services are also supporting overall market growth.

Fertility Services & IVF Technology Market – By Technology & Equipment

• Introduction/Key Findings
• Imaging Systems (Ultrasound & Microscopy)
• IVF Laboratory Equipment (Incubators, Micromanipulators)
• Cryopreservation Systems
• Sperm Processing Equipment
• Ovum Aspiration Pumps
• Time-lapse Imaging Systems
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

Fertility Services & IVF Technology Market – By Patient Type

• Introduction/Key Findings
• Female Infertility
• Male Infertility
• Combined Infertility
• Unexplained Infertility
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

Fertility Services & IVF Technology Market – By End User

• Introduction/Key Findings
• Fertility Clinics
• Hospitals
• Surgical Centers
• Cryobanks
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

Based on end user, fertility clinics accounted for the largest share of the market in 2025, supported by the growing demand for infertility treatments and the availability of specialized reproductive care services. These clinics are gaining popularity due to their focused treatment approach, affordable service packages, and improving pregnancy success rates.

Meanwhile, the hospitals segment is expected to grow at a significant rate during the forecast period. Hospitals are increasingly expanding their reproductive healthcare offerings, including prenatal care, gynecology, family planning, and fertility-related services, helping improve access to comprehensive fertility treatment options.

Regional Analysis

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Europe accounted for the largest share of the fertility services market in 2025, supported by rising infertility rates, favorable government initiatives, and increasing adoption of advanced fertility treatments. Countries such as Germany and United Kingdom continue to see strong demand due to delayed parenthood trends and supportive fertility regulations.

Meanwhile, the Asia Pacific and Latin America regions are expected to register significant growth during the forecast period. Increasing fertility tourism, improving healthcare infrastructure, rising infertility awareness, and affordable treatment options in countries such as India, Thailand, and Brazil are contributing to regional market expansion.

Latest Market News

In June 2023, Quantum Health partnered with Progyny, Inc. to expand access to family-building and fertility support services through Quantum Health’s Comprehensive Care Solutions platform.

In April 2023, Cryoport, Inc. entered into a three-year supply chain agreement with Boston IVF to support the transportation and management of reproductive materials across the United States.

Key Players

1. PFCLA
2. Mayo Foundation for Medical Education and Research (MFMER)
3. King’s Fertility Limited
4. Europe IVF
5. Care Fertility
6. Monash IVF Group
7. Cleveland Clinic
8. Dallas IVF
9. Midwest Fertility Specialists
10. Apricity Fertility UK Limited

Questions buyers ask before purchasing this report

What exactly does this report measure?

It measures the total revenue generated from fertility treatments and the technologies that support them. This includes clinical procedures like IVF and ICSI, as well as lab equipment and cryopreservation systems. It excludes unrelated healthcare services to maintain a clear market boundary.

Does the report separate treatment types clearly?

Yes, it breaks down treatments such as IVF, ICSI, IUI, and genetic testing into distinct categories. This helps avoid overlap and ensures each segment reflects a unique revenue stream.

How are market sizes calculated?

The report uses both bottom-up and top-down approaches. Bottom-up analysis is based on treatment volumes and pricing, while top-down uses broader healthcare spending trends. These are reconciled to ensure consistency.

Are success rates included in the analysis?

Success rates are considered, but they are segmented by patient type and treatment method. This avoids misleading averages and provides a more realistic view of outcomes.

Does the report account for regional differences?

Yes, it includes geographic segmentation to reflect differences in regulation, access, and adoption of technologies across regions.

How does the report handle technology vs service overlap?

The report maintains a clear boundary by focusing on the operating revenue generated within the fertility ecosystem. It avoids double counting by separating service and technology contributions.

Is primary research included?

Yes, insights are validated through interviews with clinicians, lab professionals, and industry experts across the value chain.

Can this report support investment decisions?

Yes, it provides a structured view of demand, technology adoption, and operational dynamics, helping buyers assess opportunities and risks.